Skip to main content
main-content

Metformin

News

11-07-2017 | Pregnancy | News

October Cochrane review round-up

The two diabetes-related Cochrane reviews published in October focused on diabetes during pregnancy; the first covered different methods of glucose monitoring, while the second compared oral antidiabetic agents with insulin, with both concluding that better quality research is needed to draw firm conclusions.

11-06-2017 | Prediabetes | News

Lifestyle interventions have most staying power for diabetes prevention

A meta-analysis shows that although medications and lifestyle changes can both reduce the risk for type 2 diabetes in high-risk patients, only lifestyle modifications have a sustained effect.

10-25-2017 | Dipeptidyl peptidase-4 inhibitors | News

Metformin may moderate DDP-4 inhibitor effect on cardiovascular outcomes

Metformin status at the time of initial dipeptidyl peptidase 4 inhibitor use may influence the effect these agents have on cardiovascular outcomes, be it positive or negative, suggest results of a hypothesis-generating meta-analysis.

Read more

Related topics

Superior

Related

Opinion

11-22-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

05-08-2017 | Metformin | Editorial | Article

Metformin: What is new with this old medication?

With the arrival of slow-release formulations of metformin and the relaxation of guidelines concerning its use in patients with kidney disease, Carol Wysham explains how the population of patients who might benefit from this medication has expanded.

Journal articles and book chapters

09-28-2017 | Type 2 diabetes | Book chapter | Article

Diabetes Prevention Program (DPP) and the Action for Health in Diabetes (Look AHEAD) study: Lessons learned

This chapter reviews the lessons learned from the Diabetes Prevention Program and the Action for Health in Diabetes studies regarding the health benefits of increasing physical activity in type 2 diabetes.

Gibbs BB, Jakicic JM. In: Diabetes and Exercise. Edited by Reusch JEB, Regensteiner JG, Stewart KJ, Veves A. Springer International Publishing AG, 2018. pp:175–184.

09-27-2017 | Dyslipidemia | Review | Article

Treatment of dyslipidemia in diabetes: Recent advances and remaining questions

This review summarizes the current knowledge concerning diabetic dyslipidemia and cardiovascular disease (CVD), including specific strategies to reduce diabetes-associated CVD.

Chait A, Goldberg I. Curr Diab Rep 2017;17:112. doi:10.1007/s11892-017-0942-8

09-08-2017 | Latent autoimmune diabetes of adulthood | Review | Article

Nature Reviews Endocrinology

Adult-onset autoimmune diabetes: Current knowledge and implications for management

Buzzetti et al. review the pathophysiology and clinical features of adult-onset autoimmune diabetes and highlight the similarities and differences of the condition with type 1 and type 2 diabetes.

Nat Rev Endocrinol 2017;13:674–686. doi:10.1038/nrendo.2017.99

Authors:
Raffaella Buzzetti, Simona Zampetti, Ernesto Maddaloni
image credits